Patent details

EP1711188 Title: ANTI-CANCER THERAPIES

Basic Information

Publication number:
EP1711188
PCT Application Number:
PCT/US/2005/003370
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP057127144
PCT Publication Number:
WO/2005/076888
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-CANCER THERAPIES
French Title of Invention:
THERAPIES ANTICANCEREUSES
German Title of Invention:
KREBSTHERAPIEN
SPC Number:

Dates

Filing date:
04/02/2005
Grant date:
06/06/2012
EP Publication Date:
06/06/2012
PCT Publication Date:
25/08/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/10/2006
EP B1 Publication Date:
06/06/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
04/02/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/02/2005
 
 

Name:
Threshold Pharmaceuticals Inc.
Address:
1300 Seaport Boulevard, 5th Floor, Redwood City, CA 94063, United States (US)

Agent

Name:
ARONOVA S.A.
From:
30/08/2012
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

Name:
TIDMARSH George
Address:
United States (US)

Priority

Priority Number:
542494 P
Priority Date:
06/02/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/7068;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
29/01/2024
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages